ARTICLES ON MISCELLANEOUS
Thoracoscopic Closure of the Left Atrial Appendage: AtriClip® or Stapler?
This study compares outcomes of thoracoscopic left atrial appendage (LAA) closure using the AtriClip® or an automatic stapler.
The Ebstein anomaly and the difficulty in drawing conclusions for decision-making
Results from the experience of six centers in Australia and New Zealand in the management of Ebstein anomaly over 34 years.
On-X® Aortic Prosthesis Carriers in Aortic Position: Is This the End of Anticoagulation Demonization?
This study confirms the findings of the PROACT trial on the safety profile of reducing oral anticoagulation in patients with an On-X® prosthetic valve in the aortic position.
New procedures for a minimally invasive era: transapical beating-heart septal myectomy for hypertrophic obstructive cardiomyopathy.
This study, conducted as a prospective, single-center (Tongji Hospital in Wuhan, China), single-arm trial by a single surgeon, is the first in humans to assess the transapical beating-heart septal myectomy (TA-BSM) procedure.
Aortic Graft Infection: transposition of the greater omentum
This single-center retrospective study examines outcomes with omental transposition in the mediastinum for treating infected aortic grafts.
What does closing the left atrial appendage during mitral repair offer in patients without atrial fibrillation?
This single-center, retrospective study compares the utility of left atrial appendage (LAA) closure in patients undergoing mitral valve repair without atrial fibrillation (AF).
Isolated Surgical Closure of the Left Atrial Appendage with Automated Devices: Incidence of Acute Thrombosis
This retrospective single-center study examines the incidence of acute thrombosis at the stump line of the left atrial appendage (LAA) and its prognosis following isolated surgical closure with automated devices.
A review of myocardial protection in cardiac surgery: a retrospective since 2020
This literature review revisits the pathophysiological principles of ischemia, reperfusion, and myocardial ischemia tolerance, as well as the concepts of myocardial protectioN and the main evidence on outcomes among different cardioplegia solutions retrospectively since 2020.
Mortality and Cost of Cardiac Stimulation Device Infections According to the Applied Treatment: Expert Commentary
Dr. Encarnación Gutiérrez’s review discusses the current state of managing infections associated with cardiac stimulation devices (CSDs), addressing the increase in associated costs due to three primary factors.
Are leadless pacemakers a safe alternative following cardiac surgery or percutaneous valve interventions?
This single-center retrospective study analyzes the clinical and safety outcomes of leadless pacemakers in patients requiring permanent pacing after cardiac surgery or transcatheter valve intervention.